Skip to main content
. 2021 Mar 19;13(6):1403. doi: 10.3390/cancers13061403

Table 1.

Association between DCBLD2 mRNA expression and clinicopathological features of patients with LUAD from the TCGA database. Cut off: 12.9 FPKM, * p < 0.05, ** p < 0.01, Chi-square test.

Characteristics Total
(n = 513)
DCBLD2 Expression χ2 p Value
Low (n = 339) High (n = 114)
Gender 1.475 0.225
Male 222 167 55
Female 291 232 59
Age(year) 0.323 0.570
<65 237 187 50
≥65 276 212 64
T staging 1.679 0.195
T1–T2 446 351 95
T3–T4 67 48 19
Nodal staging 7.360 0.007 **
N0 338 275 63
N1–N3 175 124 51
M staging 0.589 0.443
M0 488 378 110
M1 25 21 4
TNM 6.063 0.014 *
I 277 227 50
II,III,IV 236 172 64